Andrew Huberman Biography Flash a weekly Biography.
Andrew Huberman has spent the past few days sharpening the next chapter of his public persona: a Stanford neuroscientist increasingly positioning himself at the intersection of human performance, artificial intelligence, and big-tent live events. According to Huberman’s own post on X, a major new Huberman Lab episode dropped on August 10, featuring AI pioneer Dr Fei-Fei Li and billed as “Using AI to Increase Your Intelligence and Enrich Humanity.” In that episode and its Apple Podcasts listing, he frames AI as a tool to augment human agency, intelligence and creativity, not replace them, underscoring his evolving role as a commentator on how technology reshapes the nervous system, learning, and behavior.
Singjupost’s transcript of that Fei-Fei Li interview captures Huberman using the episode intro to promote three large-scale live events tied to his forthcoming book, Protocols: an Operating Manual for the Human Body. He announces Radio City Music Hall in New York on September 17, the Dolby Theatre in Los Angeles on October 8, and the Masonic in San Francisco on October 28, framing them as deep dives into the book plus live audience Q and A. The Radio City account on X amplifies this, touting “Protocols with Andrew Huberman” and detailing presale and on-sale windows, while a recent listing from Madison Square Garden’s event site confirms the Radio City date, time, and branding around Protocols.
Dolby Theatre’s Facebook page echoes the same momentum, promoting the October 8 Los Angeles event as “just announced” with ticket presales beginning August 13 and general sales August 14. On the business and media front, a press release from Peptide Pod highlights that the platform is curating peptide-related shows and explicitly names Andrew Huberman’s content among its featured podcasts, signaling his ongoing integration into niche health and longevity media ecosystems.
Meanwhile, the Huberman Lab feed continues to release new material beyond AI: an August 13 “Essentials” episode with Dr Sara Gottfried focuses on optimizing female hormone health for vitality and longevity, reinforcing his brand of protocol-driven health guidance for a broad audience. Social clips on Facebook tease immune system content with immunologist Max Krummel and promote the September 15 release of Protocols via Simon & Schuster and the dedicated protocolsbook.com site, positioning the book as a navigable operating manual for the body.
One recent health-policy article from AJMC notes that Huberman previously dubbed the weight-loss drug retatrutide “a trillion-dollar drug” in a 2026 interview, a phrase now being picked up by medical and financial press as shorthand for its perceived commercial potential. That comment, while not new in the past 24 hours, is being reframed as biographically significant, showcasing his growing influence in mainstream conversations about cutting-edge pharmaceuticals.
There are ongoing summaries and recaps of his AI episode on services like Shortform, but any rumors about additional secret projects or behind-the-scenes deals remain unconfirmed and should be treated as speculation unless corroborated by Huberman or primary outlets.
Thank you for listening, and be sure to subscribe so you never miss an update on Andrew Huberman, and search the term Biography Flash for more great biographies. Thanks for listening. This has been a Quiet Please production.
Get the best deals https://amzn.to/3ODvOta
